Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 3.0 | 10.0 | 0.0 | 3.0 | 0.8 | 0.9 | 1.0 | 0.9 |
| Revenue growth | -70.0% | | -100.0% | 258.2% | -5.8% | -14.5% | 12.4% | -54.7% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 3.0 | 10.0 | 0.0 | 3.0 | 0.8 | 0.9 | 1.0 | 0.9 |
| Gross margin | 100.0% | 100.0% | | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Selling, general and administrative | | | | | | | | |
| Research and development | 34.3 | 30.1 | 48.6 | 38.7 | 17.0 | 10.7 | 4.7 | 0.3 |
| General and administrative | 22.8 | 23.8 | 20.7 | 20.1 | 10.9 | 13.3 | 14.3 | 3.7 |
| EBITA | -57.3 | -80.0 | -71.9 | -57.0 | -27.3 | -23.2 | -18.0 | -3.1 |
| EBITA margin | -1908.5% | -800.2% | | -1900.1% | -3265.9% | -2610.1% | -1731.5% | -337.5% |
| Amortization of intangibles | 0.1 | 1.4 | 5.2 | 1.2 | 0.5 | 0.7 | 0.5 | 0.0 |
| EBIT | -57.4 | -81.4 | -77.1 | -58.2 | -27.8 | -23.9 | -18.5 | -3.1 |
| EBIT margin | -1912.3% | -814.2% | | -1940.2% | -3325.7% | -2686.3% | -1783.3% | -338.5% |
| Pre-tax income | -84.9 | -84.2 | -76.3 | -56.7 | -27.3 | -21.9 | -14.5 | -26.8 |
| Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -84.9 | -84.2 | -76.3 | -56.7 | -27.3 | -21.9 | -14.5 | -29.7 |
| Net margin | -2831.2% | -842.3% | | -1890.3% | -3263.9% | -2460.4% | -1396.7% | -3205.7% |
| |
| Diluted EPS | ($0.86) | ($0.91) | ($1.51) | ($1.19) | ($0.66) | ($0.64) | ($0.53) | ($15.26) |
| Shares outstanding (diluted) | 98.4 | 92.7 | 50.4 | 47.5 | 41.6 | 34.2 | 27.6 | 1.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|